Elecsys HSV-2 IgG (08948887160)
FDA 510(k) K220924 · Roche Diagnostics
510(k) numberK220924
Submission
- Device name
- Elecsys HSV-2 IgG (08948887160)
- Applicant
- Roche Diagnostics
Indianapolis, IN, US - Received
- March 31, 2022
- Decision date
- October 12, 2022
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- MYF – Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3305
- Specialty
- Microbiology
Other 510(k)s with product code MYF
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K243575 | ARCHITECT HSV-2 IgG, ARCHITECT HSV-2 IgG Calibrator, ARCHITECT HSV-2 IgG ControlsMYF · Traditional | Biokit, S.A. | 02/12/2025SE |
| K181514 | SeraQuest HSV Type 2 Specific IgGMYF · Traditional | Quest International, Inc. | 06/13/2019SE |
| K181334 | ADVIA Centaur Herpes-2 IgGMYF · Traditional | Biokit, S.A. | 08/23/2018SE |
| K152353 | SeraQuest HSV Type 2 Specific IgGMYF · Traditional | Quest International, Inc. | 05/13/2016SE |
| K103603 | Zeus Elisa HSV GG-2 Igg Test SystemMYF · Traditional | Zeus Scientific, Inc. | 05/20/2011SE |
| K081687 | Liaison HSV-2 Type Specific Igg Assay, Control HSV-2 IggMYF · Traditional | DiaSorin, Inc. | 11/10/2008SE |
| K061239 | Euroimmun ANTI-HSV-2 Elisa (Igg) and ANTI-HSV-1 Elisa (Igg) KitMYF · Traditional | Euroimmun Us, LLC | 06/28/2007SE |
| K033106 | Captia HSV 2 Igg Type Specific Elisa KitMYF · Traditional | Trinity Biotech USA | 07/13/2004SE |
| K993724 | HSV-2 Elisa Igg, Model EL0920GMYF · Traditional | Mrl Diagnostics | 02/01/2000SE |
More from Mrl Diagnostics
| 510(k) | Device | Decision |
|---|---|---|
| K261686 | Elecsys Phospho-Tau (217P) PlasmaSET · Traditional | 08/19/2026SE |
| K252323 | cobas pulse blood glucose monitoring systemPZI · Dual Track | 06/12/2026SE |
| K252431 | Elecsys CalcitoninJKR · Traditional | 04/24/2026SE |
| K252280 | Elecsys Anti-SARS-CoV-2 SQVP · Traditional | 04/13/2026SE |
| K260049 | Elecsys Anti-HBc IgMSEI · Traditional | 04/07/2026SE |
| K260048 | Elecsys Anti-HAV IgMLOL · Traditional | 04/07/2026SE |
| K260046 | Elecsys Anti-HBc IISEI · Traditional | 04/07/2026SE |
| K260026 | Tina-quant Cardiac high sensitivity CRP IIINQD · Traditional | 04/02/2026SE |
| K253491 | ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas…CEM · Traditional | 02/12/2026SE |
| K253490 | Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsCFR · Traditional | 02/12/2026SE |
Questions and answers
When was Elecsys HSV-2 IgG (08948887160) cleared by the FDA?
Elecsys HSV-2 IgG (08948887160) (K220924) received a 510(k) decision of Substantially Equivalent on October 12, 2022, 195 days after the submission was received.
What is the product code of K220924?
The FDA product code is MYF – Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2, a Class II (moderate risk) device regulated under 21 CFR 866.3305.